Quarterly Results

  • Company Name :
Glaxosmithkline Pharmaceuticals Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 500660
  • NSE Symbol:
  • GLAXO
  • P/E(TTM):
  • 55.18
  • ISIN Demat:
  • INE159A01016
  • Div & Yield%:
  • 1.16
  • EPS(TTM):
  • 49.99
  • Book Value(₹):
  • 98.85
  • Market Cap(₹Cr.):
  • 46,727.27
  • Face Value(₹):
  • 10.00
Quarters :  
Particulars December 2024 ( Cr)September 2024 ( Cr)June 2024 ( Cr)
Gross Sales 946.36 1,000.05 811.00
Excise Duty 0.00 0.00 0.00
Net Sales 946.36 1,000.05 811.00
Other Operating Income 0.00 0.00 0.00
Other Income 35.06 36.88 35.85
Total Income 981.42 1,036.93 846.85
Total Expenditure 656.18 681.10 581.58
PBIDT 325.24 355.83 265.27
Interest 0.09 0.27 0.37
PBDT 325.15 355.56 264.90
Depreciation 18.80 16.86 16.41
Tax 73.05 97.46 63.33
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 4.72 -7.45 3.51
Reported Profit After Tax 228.58 248.69 181.65
Extra-ordinary Items 0.00 3.34 0.00
Adjusted Profit After Extra-ordinary item 228.58 245.35 181.65
EPS (Unit Curr.) 13.49 14.45 10.72
EPS (Adj) (Unit Curr.) 13.49 14.45 10.72
Calculated EPS (Unit Curr.) 13.49 14.68 10.72
Calculated EPS (Adj) (Unit Curr.) 13.49 14.68 10.72
Calculated EPS (Ann.) (Unit Curr.) 53.97 58.72 42.89
Calculated EPS (Adj) (Ann.) (Unit Curr.) 53.97 58.72 42.89
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 240.00 120.00 0.00
Equity 169.41 169.41 169.41
Reserve & Surplus 0.00 0.00 0.00
Face Value 10.00 10.00 10.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 34.37 35.58 32.71
PBDTM(%) 34.36 35.55 32.66
PATM(%) 24.15 24.87 22.40